A Clinical Playbook Driven By Integrated Data
Posted on March 21, 2024
Your Definitive Guide to Ensuring Peak Performance of Your Pharmacy Program
Managing the pharmacy program has never been more complex for plan sponsors. Innovative drugs that cure disease, manage obesity, and provide quality of life to patients have flooded the market. The challenge is that these medications can cost tens of thousands, even millions, of dollars for a single treatment. How can plan sponsors effectively manage affordability?
It’s time to recruit integrated data to your starting lineup.
Understanding your integrated data can often be paramount to the success of managing your organization’s pharmacy benefit plan. The playbook covers go-to plays for the hottest topics in pharmacy benefits:
- GLP-1s: Ensure appropriate use of GLP-1s to mitigate costs and limit off-label utilization.
- Biosimilars: Identify current biosimilar utilization and identify opportunities to optimize cost savings
- Cell and Gene Therapies (CGT): Identify patients who could be a potential candidate for a CGT and anticipate costs.
- Alzheimer’s: Identify patients likely to benefit from new medications and anticipate costs.
